130 related articles for article (PubMed ID: 21105974)
1. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Arora R; Gupta D; Goyal J; Kaur R
Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
[TBL] [Abstract][Full Text] [Related]
2. Regression Discontinuity and Randomized Controlled Trial Estimates: An Application to The Mycotic Ulcer Treatment Trials.
Oldenburg CE; Venkatesh Prajna N; Krishnan T; Rajaraman R; Srinivasan M; Ray KJ; O'Brien KS; Glymour MM; Porco TC; Acharya NR; Rose-Nussbaumer J; Lietman TM
Ophthalmic Epidemiol; 2018 Aug; 25(4):315-322. PubMed ID: 29718751
[TBL] [Abstract][Full Text] [Related]
3. Update on the Management of Infectious Keratitis.
Austin A; Lietman T; Rose-Nussbaumer J
Ophthalmology; 2017 Nov; 124(11):1678-1689. PubMed ID: 28942073
[TBL] [Abstract][Full Text] [Related]
4. Efficacy Profile of Intracameral Amphotericin B. The Often Forgotten Step.
Sharma B; Kataria P; Anand R; Gupta R; Kumar K; Kumar S; Gupta R
Asia Pac J Ophthalmol (Phila); 2015; 4(6):360-6. PubMed ID: 26181588
[TBL] [Abstract][Full Text] [Related]
5. Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial.
Rajaraman R; Bhat P; Vaidee V; Maskibail S; Raghavan A; Sivasubramaniam S; Namperumalsamy VP
Asia Pac J Ophthalmol (Phila); 2015; 4(3):146-50. PubMed ID: 26065500
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole-impregnated multilayered AMT and intracorneal plus intracameral injection in recalcitrant fungal corneal ulcer.
Sharma A; Sharma R; Nirankari VS
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35351742
[TBL] [Abstract][Full Text] [Related]
7. A comparison of antimicrobial regimen outcomes and antibiogram development in microbial keratitis: a prospective cohort study in Alexandria, Egypt.
Nayel AA; Hamdy NA; Massoud TH; Mohamed NM
Graefes Arch Clin Exp Ophthalmol; 2024 Jun; 262(6):1865-1882. PubMed ID: 38240778
[TBL] [Abstract][Full Text] [Related]
8. Natamycin and Voriconazole Exhibit Synergistic Interactions with Nonantifungal Ophthalmic Agents against
Rees CA; Bao R; Zegans ME; Cramer RA
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010869
[TBL] [Abstract][Full Text] [Related]
9. Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis.
Cai J; Yang C; Wei Q; Lian H; An L; Zhang R
Pak J Med Sci; 2023; 39(3):775-779. PubMed ID: 37250561
[TBL] [Abstract][Full Text] [Related]
10. Visual Impairment in Fungal Versus Bacterial Corneal Ulcers 4 Years After Successful Antimicrobial Treatment.
Prajna NV; Srinivasan M; Mascarenhas J; Lalitha P; Rajaraman R; McClintic SM; O'Brien KS; Ray KJ; Acharya NR; Lietman TM; Keenan JD
Am J Ophthalmol; 2019 Aug; 204():124-129. PubMed ID: 30902692
[TBL] [Abstract][Full Text] [Related]
11. Debulking corneal biopsy with tectonic amniotic membrane transplantation in refractory clinically presumed fungal keratitis.
Eleiwa TK; Youssef GH; Elsaadani IA; Abdelrahman SN; Khater AA
Sci Rep; 2024 Jan; 14(1):521. PubMed ID: 38177182
[TBL] [Abstract][Full Text] [Related]
12. Nanomicelles empower natamycin in treating fungal keratitis: An in vitro, ex vivo and in vivo study.
Sathe P; Kailasam V; Nagarjuna V; Sharma H; Velpandian T; Garg P; Nirmal J
Int J Pharm; 2024 May; 656():124118. PubMed ID: 38615806
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Topical Antifungal Drugs in the Management of Fungal Keratitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
McDonald EM; Ram FS; Patel DV; McGhee CN
Asia Pac J Ophthalmol (Phila); 2014; 3(1):41-7. PubMed ID: 26107307
[TBL] [Abstract][Full Text] [Related]
14. Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial.
Rajaraman R
Asia Pac J Ophthalmol (Phila); 2015; 4(6):399. PubMed ID: 26716437
[No Abstract] [Full Text] [Related]
15. Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial.
Ravuri S; Mittal R; Bagga B
Asia Pac J Ophthalmol (Phila); 2015; 4(6):399. PubMed ID: 26716436
[No Abstract] [Full Text] [Related]
16. Validation of the C-DU(KE) Calculator as a Predictor of Outcomes in Patients Enrolled in Steroids for Corneal Ulcer and Mycotic Ulcer Treatment Trials.
Arboleda A; Prajna NV; Lalitha P; Srinivasan M; Rajaraman R; Krishnan T; Mousa HM; Feghali J; Acharya NR; Lietman TM; Perez VL; Rose-Nussbaumer J
Cornea; 2024 Feb; 43(2):166-171. PubMed ID: 37335849
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of intrastromal voriconazole injections in recalcitrant deep fungal keratitis: Case series.
Sejournet L; Drevon A; Burillon C; Mouchel R
J Fr Ophtalmol; 2024 May; 47(5):104010. PubMed ID: 37923697
[No Abstract] [Full Text] [Related]
18. Current perspectives on ophthalmic mycoses.
Thomas PA
Clin Microbiol Rev; 2003 Oct; 16(4):730-97. PubMed ID: 14557297
[TBL] [Abstract][Full Text] [Related]
19. Antifungal Efficacy of Luliconazole in an Experimental Rabbit Model of Fungal Keratitis Caused by Fusarium solani.
Arimoto S; Inagaki K; Todokoro D; Suzuki T; Makimura K; Ishino T
Mycopathologia; 2023 Oct; 188(5):775-782. PubMed ID: 37603230
[TBL] [Abstract][Full Text] [Related]
20. Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies.
El-Emam GA; Girgis GNS; El-Sokkary MMA; El-Azeem Soliman OA; Abd El Gawad AEGH
Int J Nanomedicine; 2020; 15():7825-7840. PubMed ID: 33116503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
